Key points are not available for this paper at this time.
Interview with Dr. Ryan Corcoran on the potential clinical applications of cell-free DNA analysis in patients with cancer. (10:36)Download The capacity to detect new cancers, treatment-resistant variants, and tumor heterogeneity by noninvasive technology on the basis of tumor DNA in the blood promises to revolutionize cancer detection, prevention, and treatment.
Corcoran et al. (Wed,) studied this question.